The medical landscape for diabetes is evolving, and transdermal GLP-1 delivery systems represent a potential advance. Unlike subcutaneous injections, this technique offers a less invasive way to administer GLP-1 drugs. These patches gradually release the medication through the surface offering a consistent dose of the therapeutic agent, which ca… Read More